This study aimed to evaluate the value of serum intact fibroblast growth factor 23 (iFGF23), C-terminal FGF23 (cFGF23), and kidney injury molecule-1 (KIM-1) in predicting acute kidney injury (AKI) onset, severity, and renal function recovery in critically ill patients. The gene discussed is FGF23; the disease is acute kidney injury.